149 related articles for article (PubMed ID: 33379285)
21. Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma.
Ye Z; Sun B; Xiao Z
Gene; 2020 Jul; 749():144669. PubMed ID: 32298761
[TBL] [Abstract][Full Text] [Related]
22. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
23. Multi-Omics Analysis of Cancer Cell Lines with High/Low Ferroptosis Scores and Development of a Ferroptosis-Related Model for Multiple Cancer Types.
Shan G; Zhang H; Bi G; Bian Y; Liang J; Valeria B; Zeng D; Yao G; Zhan C; Fan H
Front Cell Dev Biol; 2021; 9():794475. PubMed ID: 34938739
[No Abstract] [Full Text] [Related]
24. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
25. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
Tan Y; Ge G; Pan T; Wen D; Gan J
Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
[TBL] [Abstract][Full Text] [Related]
26. Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
Benson EA; Skaar TC; Liu Y; Nephew KP; Matei D
PLoS One; 2015; 10(10):e0141279. PubMed ID: 26485143
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
28. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
Ma C; Zhang W; Wu Q; Liu Y; Wang C; Lao G; Yang L; Liu P
PLoS One; 2018; 13(3):e0193625. PubMed ID: 29513728
[TBL] [Abstract][Full Text] [Related]
29. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
30. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.
Fekete JT; Ősz Á; Pete I; Nagy GR; Vereczkey I; Győrffy B
Gynecol Oncol; 2020 Mar; 156(3):654-661. PubMed ID: 31973910
[TBL] [Abstract][Full Text] [Related]
31. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
Niwa Y; Yamada S; Sonohara F; Kurimoto K; Hayashi M; Tashiro M; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
J Transl Med; 2019 Jan; 17(1):1. PubMed ID: 30602370
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.
Slotta-Huspenina J; Drecoll E; Feith M; Habermehl D; Combs S; Weichert W; Bettstetter M; Becker K; Langer R
J Transl Med; 2018 Apr; 16(1):109. PubMed ID: 29695253
[TBL] [Abstract][Full Text] [Related]
33. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
[TBL] [Abstract][Full Text] [Related]
34. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
36. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Hu S; Yuan Y; Song Z; Yan D; Kong X
Cell Physiol Biochem; 2018; 51(6):2509-2522. PubMed ID: 30557872
[TBL] [Abstract][Full Text] [Related]
37. Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.
Desrichard A; Kuo F; Chowell D; Lee KW; Riaz N; Wong RJ; Chan TA; Morris LGT
J Natl Cancer Inst; 2018 Dec; 110(12):1386-1392. PubMed ID: 29659925
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
Luo SS; Liao XW; Zhu XD
J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
[No Abstract] [Full Text] [Related]
40. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
Yerukala Sathipati S; Ho SY
Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
